MILLER NASHLLP ATTORNEYSATLAW | PORTLAND,OREGON SEATTLE,WASHINGTON VANCOUVER,WASHINGTON CENTRALOREGON WWW.MILLERNASH.COM | 3400 U.S. BANCORP TOWER 111 S.W. FIFTH AVENUE PORTLAND, OREGON 97204
OFFICE 503.224.5858 FAX 503.224.0155 |
July 2, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Division of Corporation Finance
| Subject: | CytoDyn Inc. | |
Preliminary Proxy Materials 2014 Annual Meeting of Shareholders |
Ladies and Gentlemen:
On behalf of CytoDyn Inc. (“CytoDyn”), submitted for filing pursuant to Rule 14a-6(a) are the following preliminary proxy materials:
| 1. | Cover page for Schedule 14A; |
| 2. | Preliminary Proxy Statement; and |
| 3. | Form of proxy card. |
CytoDyn plans to file and distribute definitive proxy materials to shareholders beginning July 18, 2014. Please consider the undersigned and Michael D. Mulholland, CytoDyn’s Chief Financial Officer, as contacts for the subject filing. Mr. Mulholland can be reached at (360) 980-8524, or by email tommulholland@cytodyn.com. My contact information is below.
Very truly yours,
/s/ David G. Post
(503) 205-2517
david.post@millernash.com
cc. Michael D. Mulholland
